t(6;11)(q27;q23) KMT2A/AFDN

Show simple item record

dc.contributor.author Huret, Jean-Loup -
dc.date.accessioned 2018-11-08T09:41:10Z
dc.date.available 2018-11-08T09:41:10Z
dc.date.issued 2018 -
dc.identifier.citation Jean-Loup, Huret. t(6;11)(q27;q23) KMT2A/AFDN. Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2018, 7, p. 308-312 -
dc.identifier.issn 1768-3262 -
dc.identifier.uri http://hdl.handle.net/2042/68924
dc.description.abstract Review on the t(6;11)(q27;q23) involving KMT2A (better known as MLL), and AFDN (Afadin), also known as AF6 or MLLT4. It occurs in acute myeloid leukemia, at times treatment-related leukemia, B lymphoblastic leukemia, and T-cell lymphoblastic leukemia. It carries a poor prognosis. en
dc.language.iso en -
dc.publisher ARMGHM - Atlas Génétique des Cancers -
dc.relation Atlas of Genetics and Cytogenetics in Oncology and Haematology ; http://AtlasGeneticsOncology.org/Anomalies/t0611ID1015.html -
dc.relation.ispartofseries Atlas of Genetics and Cytogenetics in Oncology and Haematology en
dc.rights Open access resource - terms and conditions : http://irevues.inist.fr/utilisation -
dc.subject Chromosome 6 en
dc.subject chromosome 11 en
dc.subject t(6;11)(q27;q23) en
dc.subject KMT2A en
dc.subject MLL en
dc.subject AFDN en
dc.subject Afadin en
dc.subject AF6 en
dc.subject MLLT4 en
dc.subject acute myeloid leukemia en
dc.subject treatment-related leukemia en
dc.subject B lymphoblastic leukemia en
dc.subject T-cell lymphoblastic leukemia en
dc.subject.classification Leukaemia Section en
dc.title t(6;11)(q27;q23) KMT2A/AFDN en
dc.type Article -
dc.contributor.affiliation Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France -
dc.identifier.doi https://doi.org/10.4267/2042/68924


Files in this item

PDF 07-2017-t0611ID1015.pdf 393.0Kb

This item appears in the following Collection(s)

Show simple item record





Advanced Search